Lean breast adipocytes secrete an oxylipin that suppresses breast cancer via ferroptosis
RNA-seq (gene expression) · mouse · 30 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Topic
- Breast cancerThis series is part of our curated briefing on it.
- Samples
- 30 samples: 30 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE300839_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1282180 and SRA study SRP594672. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 30 sample titles: 30 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9069403 19870X1 SkBr3 Control Rep1
- GSM9069404 19870X2 SkBr3 Control Rep2
- GSM9069405 19870X3 SkBr3 Control Rep3
- GSM9069406 19870X4 SkBr3 Control Rep4
- GSM9069407 19870X5 SkBr3 Lean secretome Rep1
- GSM9069408 19870X6 SkBr3 Lean secretome Rep2
- GSM9069409 19870X7 SkBr3 Lean secretome Rep3
- GSM9069410 19870X8 SkBr3 Lean secretome Rep4
- GSM9069411 19870X9 SkBr3 Obese secretome Rep1
- GSM9069412 19870X10 SkBr3 Obese secretome Rep2
- GSM9069413 19870X11 SkBr3 Obese secretome Rep3
- GSM9069414 19870X12 SkBr3 Obese secretome Rep4
- GSM9069415 20999X1 E0771 Control Rep1
- GSM9069416 20999X2 E0771 Control Rep2
- GSM9069417 20999X3 E0771 Control Rep3
- GSM9069418 20999X4 E0771 Lean secretome Rep1
- GSM9069419 20999X5 E0771 Lean secretome Rep2
- GSM9069420 20999X6 E0771 Lean secretome Rep3
- GSM9069421 20999X7 E0771 Obese secretome Rep1
- GSM9069422 20999X8 E0771 Obese secretome Rep2
- GSM9069423 20999X9 E0771 Obese secretome Rep3
- GSM9069424 20999X10 NMuMG Control Rep1
- GSM9069425 20999X11 NMuMG Control Rep2
- GSM9069426 20999X12 NMuMG Control Rep3
- GSM9069427 20999X13 NMuMG Lean secretome Rep1
- GSM9069428 20999X14 NMuMG Lean secretome Rep2
- GSM9069429 20999X15 NMuMG Lean secretome Rep3
- GSM9069430 20999X16 NMuMG Obese secretome Rep1
- GSM9069431 20999X17 NMuMG Obese secretome Rep2
- GSM9069432 20999X18 NMuMG Obese secretome Rep3
- GSE104193 Hypoxia-mediated translational activation of ITGB3 in breast cancer cells enhances TGF-β signalling and malignant features in vitro and in vivo 32 samples same disease briefing · shares breast
- GSE104675 Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 6 samples same disease briefing · shares breast
- GSE10886 A Supervised Risk Predictor of Breast Cancer Based on Biological Subtypes 226 samples same disease briefing · shares breast
- GSE11121 The humoral immune system has a key prognostic impact in node-negative breast cancer 200 samples same disease briefing · shares breast
- GSE10885 An integromic analysis reveals that metaplastic carcinomas are distinct from basal-like tumors. 244 samples same disease briefing
- GSE267542 Tumor intrinsic METTL5 induces immune resistance in ovarian cancer by suppressing ferroptosis 18 samples shares ferroptosis
- GSE43770 Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 17 samples shares suppresses
- GSE305855 Casein kinase 1δ/ε inhibition suppresses CLL through cell-intrinsic and microenvironmental mechanisms [RNA-Seq] 42 samples shares suppresses
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.